Detalles de la búsqueda
1.
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
N Engl J Med
; 384(6): 512-520, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567191
2.
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.
J Am Acad Dermatol
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38556093
3.
Combining public datasets for automated tooth assessment in panoramic radiographs.
BMC Oral Health
; 24(1): 387, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532414
4.
Trial of Roflumilast Cream for Chronic Plaque Psoriasis.
N Engl J Med
; 383(3): 229-239, 2020 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32668113
5.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol
; 189(4): 392-399, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279795
6.
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis.
Clin Exp Dermatol
; 48(6): 623-630, 2023 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36794376
7.
Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL study.
Clin Exp Dermatol
; 48(7): 765-769, 2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36928932
8.
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study.
J Drugs Dermatol
; 22(2): 139-147, 2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36745371
9.
Intra-oral scan segmentation using deep learning.
BMC Oral Health
; 23(1): 643, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670290
10.
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
JAMA
; 328(11): 1073-1084, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36125472
11.
Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
J Am Acad Dermatol
; 85(1): 95-104, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32585278
12.
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.
J Drugs Dermatol
; 19(11): 1093-1100, 2020 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33196758
13.
A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities.
Dermatol Surg
; 45(7): 890-897, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30640777
14.
Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.
J Am Acad Dermatol
; 78(6): 1156-1163, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409914
15.
Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302).
J Am Acad Dermatol
; 79(5): 869-877, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29864467
16.
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
J Drugs Dermatol
; 17(9): 987-996, 2018 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30235387
17.
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis.
J Am Acad Dermatol
; 87(6): 1455-1458, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35872261
18.
Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
J Drugs Dermatol
; 16(6): 591-598, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28686777
19.
Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis.
J Drugs Dermatol
; 16(3): 234-240, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28301619
20.
Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study.
J Drugs Dermatol
; 13(1): 56-61, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24385120